Cultivating Activity, Commitment, Tolerance & Uplift Study - for Children With Chronic Pain

NCT07485426 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-03-20

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if the addition of physical exercise and mindfulness training, delivered by a mobile application, to multimodal pain rehabilitation could lead to a mor effective rehabilitation process and improved outcomes. The main questions it aims to answer are:

Does 6 weeks of app-based physical exercise and mindfulness in combination with 6 weeks of multimodal hospital based pain rehabilitation give inferior results compared to 12 weeks of multimodal hospital based pain rehabilitation? Thus the study is an inferiority trial of a scaled down pain rehabilitation period with the addition of physical exercise and mindfulness training done at home with directions from a mobile application.

Participants randomized into the active intervention will begin training for 6 weeks with the app, and continue through out the rehabilitation period. Those randomized into the control group will immediately begin pain rehabilitation as usual. All participants will wear an accelerometer bracelet for a week, before, in the middle and after the 12 week study period, and fill out a questionnaire and training logs.

Conditions

Interventions

BEHAVIORAL

Mobile-based physical exercise and mindfulness training

6 weeks of daily physical exercise and mindfulness training supported by a mobile application, as well as continous during an additational 6 weeks of multimodal hospital-based pain rehabilitation.

BEHAVIORAL

Pain rehabilitation as usual (PRAU)

12 weeks of multimodal hospital-based pain rehabilitation.

Sponsors & Collaborators

  • Linkoeping University

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-31
Primary Completion
2028-03-31
Completion
2028-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07485426 on ClinicalTrials.gov